EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, Computational Studies, and Antidiabetic Evaluation of Hydrazide Derivative: In Vitro, In Vivo and In Silico Investigation

Hayat Khan, Sana Shah, Aftab Alam, Muhammad Abbas, Tahani M Almutairi, Abdul Sadiq, Pordil Khan, Momin Khan iD

Chemistry & Biodiversity · 2026

DOI: 10.1002/cbdv.202502383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Hayat Khan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Drug Design, Hydrazines, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: King Saud University, Riyadh, Saudi Arabia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) is a group of metabolic diseases characterized by long term high blood sugar levels. This work reports the synthesis of a hydrazone Schiff base compounds based on furan‐2‐carboxylic acid by treating sulfuric acid with the starting material (furan‐2‐carboxylic acid) in ethanol solvent to get the esterified compounds. Hydrazine hydrate was then refluxed with the desired ester in ethanol solvent to get the hydrazide, which was further refluxed with 4‐fluorobenzaldehyde in ethanol containing a catalytic amount of acetic acid to get the hydrazone compound. The compound has been characterized and assessed for their in vitro α‐amylase, α‐glucosidase, antioxidant, and dipeptidyl peptidase‐IV inhibition followed by in vivo antidiabetic activity. The biological studies of the compound showed significant α‐amylase (IC 50 = 47.11) and α‐glucosidase (IC 50 = 25.91) activities superior than the standard acarbose. The compound attributed significant dipeptidyl peptidase‐IV inhibition, and also notable antioxidant potential. Furthermore, on the basis of in vitro findings this compound showed a substantial reduction of in blood glucose level in animal model and no toxicity was observed in animal model and improvement in biochemical parameters. Furthermore, the molecular docking study showed that the compound has highest binding energy with α‐amylase (−6.5) and α‐glucosidase (−6.5). Additionally, ADME analysis was performed which indicated the compound pass all rules of drug and also have high GI absorption. The synthesized compound predicted bioavailable score was high. Simulation was done for further investigation of acarbose (control) and compound 3 which result show that compound 3 is more stable as compared acarbose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsDrug DesignHydrazinesDiabetes Mellitus, ExperimentalDipeptidyl-Peptidase IV Inhibitorsalpha-GlucosidasesAnimalsalpha-AmylasesMolecular Docking SimulationGlycoside Hydrolase InhibitorsAntioxidantsStructure-Activity RelationshipMolecular StructureBlood GlucoseRatsDipeptidyl Peptidase 4Male

Stichwörter der Autor:innen

antioxidant; antidiabeticdipeptidyl peptidase‐IVfuran‐2‐carboxylic acidhydrazone‐Schiff basemolecular docking

Substanzen

Hypoglycemic Agentsalpha-Glucosidasesalpha-AmylasesHydrazinesGlycoside Hydrolase InhibitorsAntioxidantsBlood GlucoseDipeptidyl-Peptidase IV InhibitorsDipeptidyl Peptidase 4

Autor:innen und Institutionen

  • Department of Pharmacy, Abdul Wali Khan University Mardan, Mardan, Pakistan.
  • Department of Chemistry, Abdul Wali Khan University Mardan, Mardan, Pakistan.
  • School of Chemistry and Materials Science, Heilongjiang University, Harbin, Heilongjiang Province, China.
  • Department of Chemistry, Rawalpindi Women University, Rawalpindi, Pakistan.
  • Department of Chemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
  • Department of Pharmacy, Faculty of Biological Sciences, University of Malakand Chakdara, Chakdara, Khyber Pakhtunkhwa, Pakistan.

ORCID-Profile: Momin Khan

Förderung

  • King Saud University, Riyadh, Saudi Arabia

Zitieren

APA

Khan, H., Shah, S., Alam, A., Abbas, M., Almutairi, T. M., Sadiq, A., Khan, P., & Khan, M. (2026). Design, Synthesis, Computational Studies, and Antidiabetic Evaluation of Hydrazide Derivative: In Vitro, In Vivo and In Silico Investigation. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202502383

Vancouver

Khan H, Shah S, Alam A, Abbas M, Almutairi TM, Sadiq A, et al. Design, Synthesis, Computational Studies, and Antidiabetic Evaluation of Hydrazide Derivative: In Vitro, In Vivo and In Silico Investigation. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202502383

BibTeX
@article{Khan2026,
  author = {Khan, Hayat and Shah, Sana and Alam, Aftab and Abbas, Muhammad and Almutairi, Tahani M and Sadiq, Abdul and Khan, Pordil and Khan, Momin},
  title = {Design, Synthesis, Computational Studies, and Antidiabetic Evaluation of Hydrazide Derivative: In Vitro, In Vivo and In Silico Investigation},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  doi = {10.1002/cbdv.202502383}
}
Kostenlos starten →